Videos
Andrew Stainthorpe, PhD
Andrew Stainthorpe, PhD, PASLU, NICE, talks about why the FDA should not take drug cost into account when weighing the approval of expensive medications.
Related Items
Benefits of the Single Payer Perspective
Andrew Stainthorpe, PhD
Videos published on March 24, 2015
Bringing the Patient into the Conversation
Andrew Stainthorpe, PhD
Videos published on March 24, 2015
Using Research to Guide Quality and Quantity of Care
Andrew Stainthorpe, PhD
Videos published on March 24, 2015
Last modified: March 24, 2015
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME